Cabazitaxel and Urination - excessive volume - a phase IV clinical study of FDA data

Summary:

Urination - excessive volume is reported as a side effect among people who take Cabazitaxel (cabazitaxel), especially for people who are male, 60+ old, also take Ondansetron,.

The phase IV clinical study analyzes which people have Urination - excessive volume when taking Cabazitaxel. It is created by eHealthMe based on reports of 2,159 people who have side effects when taking Cabazitaxel from the FDA, and is updated regularly.

What is Cabazitaxel?

Cabazitaxel has active ingredients of cabazitaxel. eHealthMe is studying from 2,161 Cabazitaxel users. Check the latest studies of Cabazitaxel.

What is Urination - excessive volume?

Urination - excessive volume is found to be associated with 923 drugs and 1,309 conditions by eHealthMe. Check the latest studies of Urination - excessive volume.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

2,159 people reported to have side effects when taking Cabazitaxel.
Among them, 11 people (0.51%) have Urination - excessive volume.

Could Cabazitaxel cause Urination - excessive volume?

Among these 11 people:

What is the gender of people who have Urination - excessive volume when taking Cabazitaxel? *

female: 0.0 %
male: 100 %

What is the age of people who have Urination - excessive volume when taking Cabazitaxel? *

What are other drugs people take besides Cabazitaxel? *

What are other side effects people have besides Urination - excessive volume? *

Fatigue (feeling of tiredness): 11 people, 100.00%
Urination - Painful: 10 people, 90.91%
General Physical Health Deterioration (weak health status): 9 people, 81.82%
Weakness: 8 people, 72.73%
Fever: 8 people, 72.73%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 63.64%
Infection: 7 people, 63.64%
Pain In Extremity: 2 people, 18.18%
Dyspnea Exertional: 2 people, 18.18%
Haematocrit Decreased: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Cabazitaxel and have Urination - excessive volume?

- Check whether Urination - excessive volume is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cabazitaxel:

Cabazitaxel (2,161 reports)

Browse all side effects of Cabazitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urination - excessive volume:

Urination - excessive volume (923 drugs)

Browse all the conditions that are associated with Urination - excessive volume:

Urination - excessive volume (1,309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cabazitaxel (the active ingredients of Cabazitaxel) and Cabazitaxel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.